Silva Isabel Fonseca, Monteiro-Brás Tiago, Araújo Inês, Caldeira Beatriz, Rua Coelho Rui, Rodrigues Ana, Fernandes Iolanda, Xavier Pires Sara, Cabral Renata
Internal Medicine, Unidade Local de Saúde de Santo António, Porto, PRT.
Hematology, Unidade Local de Saúde de Santo António, Porto, PRT.
Cureus. 2024 Aug 18;16(8):e67124. doi: 10.7759/cureus.67124. eCollection 2024 Aug.
Systemic mastocytosis (SM) poses a diagnostic challenge. This hematologic disorder involves abnormal mast cell proliferation and concurrent tissue infiltration. SM clinical presentation is not uniform, with patients displaying a wide array of symptoms related to different organ infiltration and mast cell mediators. Splenomegaly, while not typical or specific to SM, might be present from an early stage to advanced stage, especially in the presence of thrombocytopenia. Early detection is crucial for optimal patient outcomes. We present an atypical case of SM with spleen involvement in a 63-year-old male patient with a history of persistent thrombocytopenia for five years. Upon splenectomy, histological findings were compatible with infiltration with mast cells. Remarkably, the patient showed improvement and did not require additional cytoreductive therapy. This case underlines the importance of recognizing this rare presentation and highlights the potential therapeutic role of splenectomy in aggressive SM.
系统性肥大细胞增多症(SM)带来了诊断挑战。这种血液系统疾病涉及异常肥大细胞增殖和并发的组织浸润。SM的临床表现并不一致,患者会出现与不同器官浸润和肥大细胞介质相关的一系列症状。脾肿大虽然不是SM所特有的典型表现,但从早期到晚期都可能出现,尤其是在存在血小板减少的情况下。早期检测对于患者获得最佳治疗效果至关重要。我们报告一例63岁男性SM非典型病例,该患者有持续五年的血小板减少病史,脾脏受累。脾切除术后,组织学检查结果与肥大细胞浸润相符。值得注意的是,患者病情有所改善,无需额外的减细胞治疗。该病例强调了认识这种罕见表现的重要性,并突出了脾切除术在侵袭性SM中的潜在治疗作用。